AP9000180A0 - Pharmaceutical composition for the treatment of protozoal diseases - Google Patents

Pharmaceutical composition for the treatment of protozoal diseases

Info

Publication number
AP9000180A0
AP9000180A0 AP90/00180A AP9000180A AP9000180A0 AP 9000180 A0 AP9000180 A0 AP 9000180A0 AP 90/00180 A AP90/00180 A AP 90/00180A AP 9000180 A AP9000180 A AP 9000180A AP 9000180 A0 AP9000180 A0 AP 9000180A0
Authority
AP
ARIPO
Prior art keywords
treatment
pharmaceutical composition
protozoal diseases
protozoal
diseases
Prior art date
Application number
AP90/00180A
Other versions
AP137A (en
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AP9000180A0 publication Critical patent/AP9000180A0/en
Application granted granted Critical
Publication of AP137A publication Critical patent/AP137A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1990/000180A 1989-05-05 1990-05-02 Pharmaceutical composition for the treatment of protozoal diseases particulary of trypanosomiasis, comprising D-carnitine or an acyl derivative of D-carnitine. AP137A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947916A IT1231944B (en) 1989-05-05 1989-05-05 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROTOZOOSIS, ESPECIALLY OF TRIPASONOMYASIS INCLUDING D-CARNITINE OR AN ALCANOYL DERIVATIVE OF D-CARNITINE

Publications (2)

Publication Number Publication Date
AP9000180A0 true AP9000180A0 (en) 1990-07-31
AP137A AP137A (en) 1991-08-05

Family

ID=11263328

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1990/000180A AP137A (en) 1989-05-05 1990-05-02 Pharmaceutical composition for the treatment of protozoal diseases particulary of trypanosomiasis, comprising D-carnitine or an acyl derivative of D-carnitine.

Country Status (5)

Country Link
AP (1) AP137A (en)
GB (1) GB2230953B (en)
IT (1) IT1231944B (en)
OA (1) OA09832A (en)
ZA (1) ZA903352B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254135B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, WITH ANTIBACTERIAL ACTIVITY.
IT1254136B (en) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti ACIL CARNITINE ESTERS WITH LONG CHAIN ALIPHATIC ALCOHOLS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, WITH ANTI-Fungal activity.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5058213A (en) * 1973-09-26 1975-05-21
DE2903558C2 (en) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Use of L-carnitine
DE2903579A1 (en) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti USE OF ACETYL CARNITINE AND OTHER ACYLDER DERIVATIVES OF CARNITINE FOR THE TREATMENT OF HYPERLIPOPROTEINEMIC AND HYPERLIMPIDAEMIA AND MEDICINAL PRODUCTS
IT1156769B (en) * 1978-05-25 1987-02-04 Sigma Tau Ind Farmaceuti THERAPEUTIC APPLICATION OF CARNITINE AND OTHER ACIL DERIVATIVES OF CARNITINE
IT1206954B (en) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti THERAPEUTIC AGENTS BASED ON AN ACIL DERIVATIVE OF CARNITINE FOR THE TREATMENT OF PERIPHERAL VASCULOPATHIES
JPS5661314A (en) * 1979-10-24 1981-05-26 Otsuka Pharmaceut Factory Inc Preventive against side-effect for dialytic patient
JPS57126420A (en) * 1981-01-26 1982-08-06 Eiji Murakami Drug for digestive organ
IT1142934B (en) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti USE OF CARNITINE AND LOWER ACILCARNITINES IN THE THERAPEUTIC TREATMENT OF VEIN PATHOLOGY
IT1191945B (en) * 1986-06-04 1988-03-31 Avantgarde Spa N-ALCHYLAMIDS OF D (+) - CARNITINE EQUIPPED WITH ANTIBACTERIAL ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
CH676930A5 (en) * 1988-05-26 1991-03-28 Bernardini Attilio

Also Published As

Publication number Publication date
OA09832A (en) 1994-04-15
IT8947916A0 (en) 1989-05-05
GB2230953B (en) 1993-03-24
GB9010190D0 (en) 1990-06-27
AP137A (en) 1991-08-05
IT1231944B (en) 1992-01-16
GB2230953A (en) 1990-11-07
ZA903352B (en) 1991-02-27

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions & diseases
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
EG18268A (en) Medicament for the treatment of inflammation of the eye
ZA895263B (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
HUT70034A (en) Process for preparing pharmaceutical compositions containing dipyridamole for the treatment of proliferative diseases
HU906006D0 (en) Process for the preparation of medical products
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
HU908272D0 (en) Process for the production of medical preparations for external treatment
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
IL84012A0 (en) Pharmaceutical composition for the treatment of high blood pressure
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease
AU1705783A (en) Medicine for the treatment of the neoplazic disease
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
HU895238D0 (en) Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases